Home
Conditions
Eye Neoplasms

Clinical trial condition

Eye Neoplasms

Explore clinical trials studying Eye Neoplasms. Study availability and eligibility vary by location and protocol.

396 public trials 62 recruiting studies

Refine in advanced search Browse all conditions

Eye Neoplasms trial results

Completed

Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

NCT01839916

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +134 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Completed

Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma

NCT01722305

Conditions: B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma, Burkitt Lymphoma, Central Nervous System Lymphoma, +23 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Dana-Farber Harvard Cancer Center Boston, Massachusetts, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Superselective Intra-arterial Chemotherapy Treatment for Retinoblastoma- 5 Year Results From Turkey

NCT03935074

Conditions: Eye Diseases, Eye Diseases, Hereditary, Eye Neoplasms, +11 more
Locations: Istanbul University Cerrahpasa School of Medicine Ophthalmology Department Istanbul, Turkey (Türkiye)

View Trial Details

Completed

Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic Imbalance

NCT01100528

Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma, Small Size, Eye Diseases, +15 more
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma

NCT00121225

Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size, Extraocular Extension Melanoma, Eye Diseases, +20 more
Locations: Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

Fox Chase Cancer Center Rockledge, Pennsylvania, United States

Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada

Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada

View Trial Details

Completed

Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment

NCT00005639

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

AS-OCT Guided Treatment of Diffuse CSCC

NCT03515954

Conditions: Conjunctival Diseases, Conjunctival Neoplasms, Eye Diseases, +3 more
Locations: Not specified

View Trial Details

Completed

Attention to Retinoblastoma Diagnosed in the Trauma Setting

NCT03764930

Conditions: Eye Diseases, Eye Diseases, Hereditary, Eye Neoplasms, +13 more
Locations: Zhongshan Ophthalmic Center, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Completed

Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00005092

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +77 more
Locations: University of Illinois at Chicago Chicago, Illinois, United States

Washington University Barnard Cancer Center St Louis, Missouri, United States

University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

STA-9090(Ganetespib) in Metastatic Ocular Melanoma

NCT01200238

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +12 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Eye Neoplasms

Eye Neoplasms trial results

Related conditions